"This model could create
greater exposure to adverse risk selection that is only partially offset by the
potential for narrower risk corridor protections, which may give some PDP
sponsors pause on participation."
— Larry Kocot, a principal at KPMG LLP and a former top CMS
official, spoke with AIS's RADAR
on Medicare Advantage about CMS's latest Part D innovation model,
which aims to lower seniors' insulin costs.
No comments:
Post a Comment